Extended therapeutic window for post-exposure treatment of ricin intoxication conferred by the use of high-affinity antibodies
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Israel Institute for Biological Research
This publication has 29 references indexed in Scilit:
- Novel Class of Potential Therapeutics that Target Ricin Retrograde TranslocationToxins, 2013
- Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal AntibodiesBioMed Research International, 2012
- Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunitVaccine, 2012
- Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)Vaccine, 2011
- Neutralising Antibodies against Ricin ToxinPLOS ONE, 2011
- Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screenToxicon, 2010
- Identification of new classes of ricin toxin inhibitors by virtual screeningToxicon, 2010
- Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activityBMC Biotechnology, 2009
- Immunoglobulin A Antibodies against Ricin A and B Subunits Protect Epithelial Cells from Ricin IntoxicationInfection and Immunity, 2006
- The complete amino acid sequence of the B-chain of ricin E isolated from small-grain castor bean seeds. Ricin E is a gene recombination product of ricin D and ricinus communis agglutininBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987